This Slide: #18 of 100 |
Slide #18. Mesa Laboratories, Inc. — Amilabo SAS
Acquirer:
Mesa Laboratories, Inc. (NASDAQ:MLAB)
Acquiree:
Amilabo SAS
Details:
Mesa Laboratories, Inc. (Nasdaq:MLAB) (we, us, our, "Mesa" or the "Company") today announced the acquisition of Amilabo SAS ("Amilabo"), a distributor of the Company's biological indicator (BI) products, located near Lyon, France. In this transaction, Mesa acquired all of the outstanding shares of Amilabo.
Mesa Laboratories manufactures, develops, and sells life sciences tools and quality control solutions. Co. is organized into four segments or divisions: Clinical Genomics, which develops, manufactures, and sells genetic analysis tools and related consumables and services; Sterilization and Disinfection Control, which manufactures and sells biological, chemical and cleaning indicators used to assess the effectiveness of sterilization processes; Biopharmaceutical Development, which develops, manufactures, and sells automated systems for protein analysis and peptide synthesis solutions; Calibration Solutions, which develops, manufactures, and sells quality control products .
MLAB SEC Filing Email Alerts Service
Open the MLAB Page at The Online Investor »
|
Open the MLAB Page at The Online Investor (in a new window) »
Free MLAB Email Alerts: Get SEC Filing Alerts Get Dividend Alerts |
Buy (3.33 out of 4) 47th percentile
(ranked lower than approx. 53% of all stocks covered)
Analysts' Target Price: MLAB Stock Forecast Based on Zacks ABR data; powered by Xignite |